Zhao Qi-Hui, Zhao Yun-E
Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325027, Zhejiang Province, China.
National Clinical Research Center for Ocular Diseases, Wenzhou 325027, Zhejiang Province, China.
Int J Ophthalmol. 2021 Jun 18;14(6):923-930. doi: 10.18240/ijo.2021.06.19. eCollection 2021.
As an indispensable part of congenital cataract surgery, intraocular lens (IOL) implantation in infantile patients has long-term positive impacts on visual rehabilitation, as well as postoperative complications inevitably. Timing of IOL implantation in infantile congenital cataract patients is not simply a point-in-time but a personalized decision that comprehensively takes age at surgery, risks of postoperative complications, and economic condition of family in consideration, and combines with choosing suitable IOL type and power. For infants with well-developed eyeballs and good systemic conditions, IOL implantation at six months of age or older is safe and effective. Otherwise, secondary IOL implantation may be a safer choice.
作为先天性白内障手术不可或缺的一部分，在婴幼儿患者中植入人工晶状体（IOL）对视力恢复有长期积极影响，但术后并发症也不可避免。婴幼儿先天性白内障患者人工晶状体植入的时机并非简单的一个时间点，而是一个综合考虑手术时年龄、术后并发症风险和家庭经济状况的个性化决定，并结合选择合适的人工晶状体类型和屈光度。对于眼球发育良好且全身状况良好的婴儿，6个月及以上植入人工晶状体是安全有效的。否则，二期人工晶状体植入可能是更安全的选择。
